Dragonfly Energy Holdings Corp. — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual filing; the supplied text does not provide standalone fourth-quarter results. The statements are audited, and the auditor highlighted substantial doubt about the company’s ability to continue as a going concern.
Business context
Dragonfly manufactures deep-cycle lithium iron phosphate (LFP) batteries under the Battle Born and Dragonfly brands, primarily for recreational vehicles, marine vessels and off-grid storage. It also resells battery-system accessories and is developing solid-state battery cells. The October 7, 2022 business combination was accounted for as a reverse recapitalization, with Legacy Dragonfly as the accounting acquirer.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Net sales | $86.3 million | $78.0 million |
| Gross profit / margin | $24.0 million / 27.8% | $29.6 million / 38.0% |
| Operating income (loss) | $(34.0) million | $6.5 million |
| Net income (loss) | $(39.6) million | $4.3 million |
| Adjusted EBITDA (non-GAAP) | $(7.5) million | $8.5 million |
| Cash from operating activities | $(45.7) million | $(13.6) million |
| Cash from investing activities | $(6.8) million | $(2.9) million |
| Cash from financing activities | $41.7 million | $38.9 million |
- Revenue increased 10.6% as OEM sales grew to $33.8 million from $8.2 million, while retail and distributor sales together fell to $52.4 million from $69.8 million. OEMs represented 39.2% of revenue, versus 10.5% in 2021.
- Battery units sold rose to 96,034 from 74,652. Gross margin declined as the mix shifted toward lower-margin OEM sales, costs rose and higher-margin direct sales weakened.
- General and administrative expense rose to $41.6 million from $10.6 million, including $23.4 million of business-combination and professional costs and increased public-company costs. Selling and marketing expense rose to $13.7 million from $9.8 million.
- FY2022 other expenses included $6.9 million of net interest expense and $4.8 million of debt-extinguishment expense, partly offset by a $5.4 million warrant-liability fair-value gain. The $39.6 million net loss included these unusual items.
- At year-end, cash was $17.8 million and working capital was $32.9 million. Inventory increased to $49.8 million from $27.1 million, largely reflecting purchases intended to support growth and buffer supply disruptions.
- The company raised a $75 million senior secured term loan in connection with the business combination, refinanced $45 million of prior senior notes and received a $15 million strategic investment from THOR Industries. The loan matures in October 2026, carries floating-rate interest with substantial cash and payment-in-kind components, and is secured by substantially all assets. Although the balance-sheet carrying value was $19.2 million after warrant-related debt discounts, the stated principal was $75 million, plus accrued payment-in-kind interest.
Changes, outlook and key risks
- Management plans to expand products and end markets and develop solid-state cells. It aims to begin pilot production of solid-state pouch cells by early 2024 and expects to spend more than $50 million on solid-state development and cell-manufacturing technology over the next two to three years. These are plans, not assured outcomes.
- A new 390,240-square-foot warehouse was leased for future manufacturing; construction was expected to be completed in early 2024. Management estimates the existing facility could support more than $500 million in manufacturing sales capacity when fully utilized.
- The filing reports a substantial-doubt going-concern conclusion: the company had operating losses and negative operating cash flow, received a March 2023 waiver for specified loan-covenant failures, and considered future covenant noncompliance probable within 12 months. Lenders could accelerate the loan if defaults are not waived or cured. The auditor included a going-concern explanatory paragraph.
- Management expects additional financing, including possible use of a $150 million equity facility, to support operations and investment. Facility proceeds depend on share prices and purchaser limits; share issuance may dilute existing holders and pressure the stock. Through April 17, 2023, about 98,500 shares had been sold under the facility for $0.67 million net.
- Keystone’s supply arrangement and the contemplated THOR distribution arrangement do not provide firm purchase commitments. The THOR agreement remained subject to negotiation. OEM growth may therefore be uncertain and may constrain relationships with other RV manufacturers.
- Key operating risks include dependence on two Chinese LFP-cell suppliers, one Chinese battery-management-system supplier and a single principal manufacturing facility; supply-chain, tariff and inflation exposure; product-liability and battery-safety risks; and technical, scale-up and funding risks in solid-state development.
- Management concluded disclosure controls and internal control over financial reporting were ineffective at December 31, 2022, citing material weaknesses in staffing and expertise, risk assessment, monitoring and financial-process controls. Remediation was underway but not yet established as effective.
- The merger earnout could issue up to 40 million additional shares. Its first tranche requires 2023 audited revenue of at least $250 million and operating income of at least $35 million; later tranches depend on stock-price thresholds. These are earnout conditions, not management guidance.
Important facts for investors to verify
- Current cash, operating cash burn, financing availability and compliance with each term-loan covenant; confirm the status and scope of the March 2023 waiver and any subsequent waivers or defaults.
- Term-loan principal, accrued payment-in-kind interest, cash interest burden, collateral and acceleration exposure; do not equate the $19.2 million accounting carrying value with principal outstanding.
- Whether OEM orders and the Keystone and THOR arrangements translate into recurring sales, and the resulting revenue mix, average selling prices and gross margins.
- Progress, cost and technical results for solid-state development, pilot production and facility expansion versus the stated timelines and spending plans.
- Effect of equity-facility sales, registered resales, warrants, options and earnout shares on dilution and the market price.
- Progress in remediating the disclosed material weaknesses and any subsequent changes to reported results, controls or going-concern assessment.